UPDATE: ISI Group Initiates Charles River Labs With Underweight, $34 PT Demand, Preclinical Headwinds

ISI Group initiated its coverage on Charles River Labs CRL with an Underweight rating and a price target of $34 per share. ISI Group noted, "We are initiating coverage on shares of Charles River Laboratories with an Underweight rating and a price target of $34.00, which on a forward basis equates to ~9x EV/EBITDA and ~12x operating EPS. Our thesis for CRL is based on RMS performance remaining mixed (as soft demand in small model production offsets ancillary services), continued challenges in Preclinical Services from massive global overcapacity, and the benefits from a multi-year restructuring effort." Charles River Labs closed at $32.69 on Monday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetInitiationPre-Market OutlookAnalyst RatingsISI Group
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!